Drew Taylor from Acorn Biolabs

Transition

Drew Taylor's journey from MLB pitcher to PhD holder and entrepreneur is a testament to his adaptability and ambition. Initially set to attend medical school, Drew was drafted by the Blue Jays, prompting him to pursue a PhD at the University of Toronto while playing baseball. This unique path allowed him to balance his passion for sports with his academic pursuits, ultimately leading to the founding of Acorn Biolabs. Reflecting on his baseball experience, Drew highlights the importance of teamwork in both sports and business, emphasizing how diverse skill sets contribute to success.

People are coming at this from, from very different perspectives and skill sets, and bringing all of those elements together gives you a much better opportunity to win.

--- Drew Taylor

His work in regenerative medicine began with translating successful animal studies into human models, aiming to replace prosthetics with patients' own tissues. This ambition was fueled by the realization that younger cells could significantly improve patient outcomes 1 2.

   

Business Building

Building Acorn Biolabs required Drew to assemble a diverse team, blending expertise from science, consumer products, and digital marketing. This diversity is crucial for developing Acorn's innovative cell banking service, which combines elements of SaaS and biotech. Drew acknowledges the complexity of raising capital in this space, as investors must understand both the biological and technological aspects of the business. He notes the challenge of finding investors who appreciate Acorn's dual focus on patient engagement and regenerative medicine.

It's a really interesting question. Acorn is not a totally straightforward story. Right? Like it is. What we're doing is fairly complex and articulating that.

--- Drew Taylor

Despite these challenges, Acorn has attracted a diverse group of investors, including those from pharma, venture capital, and even physicians, who value the company's mission and potential impact on healthcare 3 4 5.